Duramed Planning Cenestin DTC Ad Campaign With Marketing Partner

Duramed is planning a direct-to-consumer ad campaign with an undisclosed marketing partner for its synthetic conjugated estrogens product Cenestin, approved on March 24 for treatment of moderate-to-severe vasomotor symptoms associated with menopause.